Thermo Fisher (TMO) Tops Q4 EPS by 3c; Issues In-Line FY12 EPS Outlook, Revs Light
TMO Hot Sheet
Revenue Growth %: +14.0%Financial Fact:
Research and development expenses: 91.8M
Today's EPS Names:
TARO, BRLI, TLB, More
Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $1.18, $0.03 better than the analyst estimate of $1.15. Revenue for the quarter came in at $3.13 billion versus the consensus estimate of $3.08 billion.
Thermo Fisher Scientific sees FY2012 EPS of $4.67-$4.82, versus the consensus of $4.72. Sees FY2012 revenue of $12.15-$12.35 billion, versus the consensus of $12.56 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Thermo Fisher Scientific sees FY2012 EPS of $4.67-$4.82, versus the consensus of $4.72. Sees FY2012 revenue of $12.15-$12.35 billion, versus the consensus of $12.56 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
